We are live on ! Find out more
Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Portfolio holdings

AUM $34B
1-Year Est. Return 6.31%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+6.31%
3 Year Est. Return
+45.79%
5 Year Est. Return
+60.99%
10 Year Est. Return
+604.27%
AUM
$43.1B
AUM Growth
+$3.17B
Cap. Flow
+$277M
Cap. Flow %
0.64%
Top 10 Hldgs %
19.67%
Holding
1,006
New
45
Increased
245
Reduced
374
Closed
50

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$99.8M
2
BJ icon
BJs Wholesale Club
BJ
+$86.5M
3
DAVA icon
Endava
DAVA
+$79.7M
4
POOL icon
Pool Corp
POOL
+$66.9M
5
COO icon
Cooper Companies
COO
+$60.9M

Sector Composition

Rank Sector Weight
1 Industrials 32.65%
2 Technology 19.24%
3 Financials 18.77%
4 Consumer Discretionary 10.62%
5 Healthcare 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRE icon
676
Sempra
SRE
$56.6B
$4.96K ﹤0.01%
69
-80
-54% -$5.73K
SSNC icon
677
SS&C Technologies
SSNC
$19.3B
$4.96K ﹤0.01%
77
MTUM icon
678
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
$4.88K ﹤0.01%
+26
New +$4.54K
EQNR icon
679
Equinor
EQNR
$96.3B
$4.83K ﹤0.01%
178
GEHC icon
680
GE HealthCare
GEHC
$33.3B
$4.73K ﹤0.01%
52
-4
-7% -$333
OTEX icon
681
Open Text
OTEX
$6.05B
$4.71K ﹤0.01%
121
-6
-5% -$241
BF.B icon
682
Brown-Forman Class B
BF.B
$12.8B
$4.7K ﹤0.01%
91
-733,474
-100% -$40.8M
ETR icon
683
Entergy
ETR
$49.8B
$4.65K ﹤0.01%
88
CRH icon
684
CRH
CRH
$65.4B
$4.57K ﹤0.01%
53
+8
+18% +$612
MACK
685
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.43K ﹤0.01%
300
DLR icon
686
Digital Realty Trust
DLR
$73.3B
$4.32K ﹤0.01%
29
-1
-3% -$141
DOX icon
687
Amdocs
DOX
$6.24B
$4.25K ﹤0.01%
47
-8
-15% -$729
HUM icon
688
Humana
HUM
$46B
$4.16K ﹤0.01%
12
NUE icon
689
Nucor
NUE
$61.8B
$4.16K ﹤0.01%
21
+5
+31% +$914
D icon
690
Dominion Energy
D
$60.4B
$4.13K ﹤0.01%
84
OXY icon
691
Occidental Petroleum
OXY
$57.7B
$4.12K ﹤0.01%
63
BBVA icon
692
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
$4.07K ﹤0.01%
344
-41
-11% -$410
LNC icon
693
Lincoln National
LNC
$8.65B
$3.87K ﹤0.01%
121
F icon
694
Ford
F
$55.3B
$3.86K ﹤0.01%
291
+201
+223% +$2.44K
KEY icon
695
KeyCorp
KEY
$24.7B
$3.79K ﹤0.01%
240
TFC icon
696
Truist Financial
TFC
$64.8B
$3.7K ﹤0.01%
94
-1
-1% -$37
OVV icon
697
Ovintiv
OVV
$17.2B
$3.67K ﹤0.01%
70
SAN icon
698
Banco Santander
SAN
$211B
$3.56K ﹤0.01%
735
+120
+20% +$501
CM icon
699
Canadian Imperial Bank of Commerce
CM
$112B
$3.55K ﹤0.01%
70
BHP icon
700
BHP
BHP
$222B
$3.52K ﹤0.01%
60
-7
-10% -$419

Similar funds

Kayne Anderson Rudnick Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Kayne Anderson Rudnick Investment Management held 1,006 positions worth $43.1B, up 7.9% from $40B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Kayne Anderson Rudnick Investment Management's Q1 2024 filing shows 45 new, 245 increased, 374 reduced and 50 closed positions. Its largest new stake was Triumph Financial Inc: 734,259 shares worth $58.2M. The largest sale was Ansys, an estimated $200M.

By sector, the portfolio is most concentrated in Industrials at 33% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • Kayne Anderson Rudnick Investment Management's largest Q1 2024 buy was Triumph Financial Inc: 734,259 shares worth $58.2M.
  • Kayne Anderson Rudnick Investment Management added most to Equifax in Q1 2024, an estimated $99.8M increase.
  • Kayne Anderson Rudnick Investment Management's biggest Q1 2024 reduction was Ansys, cutting an estimated $200M.
  • Kayne Anderson Rudnick Investment Management fully exited Mesa Laboratories in Q1 2024, selling an estimated $3.25M.
  • Kayne Anderson Rudnick Investment Management's ten largest holdings make up 20% of its $43.1B portfolio in Q1 2024.
  • Kayne Anderson Rudnick Investment Management opened 45 new positions and closed 50 in Q1 2024.
  • Kayne Anderson Rudnick Investment Management's portfolio value rose 7.9% quarter-over-quarter to $43.1B.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2024, filed 14 May 2024.